Moreover, gene therapy that overexpresses regulators of mitochondrial oxidative stress and dynamics, such as PGC-1 α , HSP70, TFEB, can reduce neurotoxicity in experimental PD and HD, suggesting that these strategies may be significant therapeutic approaches for other neurodegeneration diseases 93 , 129 .
← all excerpts
Gene therapy for neurodegenerative disorders: advances, insights and prospects.
1
—
—